Archives

by in
Entry Author Date Location
Atara Bio Grabs $38.5M to Help Kidney Patients, Fight Cancer 12/17/13 San Francisco
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
How Alkermes Survived a Brush With Death 11/11/13 National
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
San Diego Life Sciences Roundup: Tandem Diabetes, Ligand, and More 10/10/13 San Diego
PharmAkea Therapeutics Receives $45,000,000 Series A Funding Round 10/08/13 San Diego
San Diego’s PharmAkea Raises Capital, Forms Alliance with Celgene 10/07/13 San Diego
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
The Best Biotech Graduate Schools in Real Life 09/23/13 National
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Investors to Get $300M as FDA Approves Celgene Drug For Pancreatic Cancer 09/06/13 New York
Starting a Company Is Hard. Good Health Insurance Makes It Easier. 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
East Coast Life Sciences Roundup: Mana, Medivizor, Regado, & More 08/23/13 New York
Join Us, and Boston’s “Life Science Disruptors,” on Oct. 2 08/21/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
Page 4 of 9 « previous page · next page »